Showing results (91-100 of 207) with videos related to
Sort By:
Pageof 21
The Western Journal of Emergency Medicine|May 25, 2019
Feasibility of Telesimulation and Google Glass for Mass Casualty Triage Education and TrainingC Eric McCoy, Rola Alrabah, Warren Weichmann, et al.Nuclear Medicine and Biology|October 1, 2016
Iodinated benzimidazole PARP radiotracer for evaluating PARP1/2 expression in vitro and in vivoRedmond-Craig Anderson, Mehran Makvandi, Kuiying Xu, et al.Stroke|June 25, 2011
Effects of blood pressure lowering on major vascular events among patients with isolated diastolic hypertension: the perindopril protection against recurrent stroke study (PROGRESS) trialHisatomi Arima, Craig Anderson, Teruo Omae, et al.American Heart Journal|June 25, 2004
Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trialsKoon Teo, Salim Yusuf, Peter Sleight, et al.The Lancet. Neurology|January 24, 2006
Ethnic disparities in incidence of stroke subtypes: Auckland Regional Community Stroke Study, 2002-2003Valery Feigin, Kristie Carter, Maree Hackett, et al.Journal of the Neurological Sciences|April 17, 2012
Revisiting cerebral thromboangiitis obliteransCarrie B Hurelbrink, Yael Barnett, Michael E Buckland, et al.Stroke|February 12, 2011
Ethnicity and functional outcome after strokeHarry McNaughton, Valery Feigin, Ngaire Kerse, et al.Plos One|November 22, 2013
A brave new world for an old world pest: Helicoverpa armigera (Lepidoptera: Noctuidae) in BrazilWee Tek Tay, Miguel F Soria, Thomas Walsh, et al.Stroke|September 6, 2005
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attackHisatomi Arima, Robert G Hart, Sam Colman, et al.The New England Journal of Medicine|April 2, 2008
Telmisartan, ramipril, or both in patients at high risk for vascular events, Salim Yusuf, Koon K Teo, et al.Pageof 21